January 5, 2025

NCI’s myeloMATCH precision medicine initiative pushes the envelop in myeloid leukemia care

October 30, 2024

ECOG-ACRIN and Caris partner to learn more from the TAILORx trial

October 25, 2024

ECOG-ACRIN and Caris to analyze samples from TAILORx (requires free registration)

October 24, 2024

The October 2024 News from ECOG-ACRIN blog is now available

October 24, 2024

Press Release: ECOG-ACRIN and Caris Life Sciences partner to interrogate landmark TAILORx breast cancer trial

October 23, 2024

Press Release: myeloMATCH precision medicine trials in myeloid leukemias open to patient enrollment across the US and Canada

September 20, 2024

The September 2024 News from ECOG-ACRIN blog is now available

September 18, 2024

Press Release: Cancer Cooperative Group leaders propose a re-engineering of the nationā€™s correlative science program for cancer

August 29, 2024

How the CompassHER2 pCR trial (EA1181) and other novel studies seek to optimize HER2+ breast cancer management

ECOG-ACRIN Cancer Research Group